###begin article-title 0
###xml 118 123 <span type="species:ncbi:9606">human</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
A necdin/MAGE-like gene in the chromosome 15 autism susceptibility region: expression, imprinting, and mapping of the human and mouse orthologues
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Proximal chromosome 15q is implicated in neurodevelopmental disorders including Prader-Willi and Angelman syndromes, autistic disorder and developmental abnormalities resulting from chromosomal deletions or duplications. A subset of genes in this region are subject to genomic imprinting, the expression of the gene from only one parental allele.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGE-G</italic>
###xml 199 202 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 220 232 220 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/MAGE-G</italic>
###xml 309 315 309 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGED1</italic>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGEL2</italic>
###xml 336 339 336 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 437 448 437 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/Ndnl2</italic>
###xml 136 142 <span type="species:ncbi:10090">murine</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
We have now identified the NDNL2 (also known as MAGE-G) gene within the 15q autistic disorder susceptibility region and have mapped its murine homolog to the region of conserved synteny near necdin (Ndn) on mouse Chr 7. NDNL2/MAGE-G is a member of a large gene family that includes the X-linked MAGE cluster, MAGED1 (NRAGE), MAGEL2 and NDN, where the latter two genes are implicated in Prader-Willi syndrome. We have now determined that NDNL2/Ndnl2 is widely expressed in mouse and human fetal and adult tissues, and that it is apparently not subject to genomic imprinting by the PWS/AS Imprinting Center.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 9 21 9 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/MAGE-G</italic>
Although NDNL2/MAGE-G in the broadly defined chromosome 15 autistic disorder susceptibility region, it is not likely to be pathogenic based on its wide expression pattern and lack of imprinted expression.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBE3A</italic>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 739 745 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGEL2</italic>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 905 908 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 935 938 935 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 957 960 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1218 1223 1218 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1341 1346 1341 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1707 1708 1707 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1709 1710 1709 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1774 1785 1774 1785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/Ndnl2</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 887 892 <span type="species:ncbi:10090">mouse</span>
###xml 914 920 <span type="species:ncbi:10090">murine</span>
###xml 1355 1361 <span type="species:ncbi:10090">murine</span>
###xml 1389 1395 <span type="species:ncbi:10090">murine</span>
###xml 1758 1763 <span type="species:ncbi:9606">human</span>
###xml 1768 1773 <span type="species:ncbi:10090">mouse</span>
Human chromosome 15q is prone to cytogenetic rearrangements, in part due to repetitive elements located therein [1,2]. Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two neurodevelopmental disorders caused by deletions of 15q11-q13, and neurodevelopmental abnormalities are associated with supernumerary chromosomes derived from inverted duplications of 15q [3]. In addition, an autistic disorder susceptibility locus has been localized to proximal 15q by linkage and association studies [4,5]. AS is associated with UBE3A mutations [6,7]. Strong candidates for PWS have recently emerged and are likely to have an additive effect in causing this disorder [8-12]. In particular, two members of the NDN/MAGE gene family, NDN and MAGEL2, are located in the PWS deletion region and are inactivated in individuals with PWS [8,11-14]. Respiratory and behavioral abnormalities in a mouse deleted for Ndn, the murine orthologue of NDN, may suggest that NDN is implicated in the PWS phenotype [15,16]. We have therefore investigated the possibility that other NDN/MAGE genes may also be present on proximal 15q and may be involved in neurodevelopmental disorders. Indeed, we identified a novel necdin-related gene, NDNL2, on proximal 15q within the critical region for autistic disorder susceptibility. We have examined the expression of NDNL2 and its murine orthologue, and placed the murine gene on Chr. 7. The proximal region of chromosome 15 is subject to genomic imprinting, the expression of a gene from only one allele depending on parent-of-origin. Furthermore, the maternal derivation of chromosome 15 abnormalities seen in individuals with autistic disorder suggests a parent-of origin effect [4,5]. We have therefore analyzed the imprinting of human and mouse NDNL2/Ndnl2.
###end p 8
###begin title 9
Results and discussion
###end title 9
###begin p 10
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 195 200 195 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APBA2</italic>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 889 890 889 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Using a BLAST search for genes with sequence similarity to NDN, NDNL2 was identified as a MAGE-like protein on the BAC clone RP11-18H24 (GenBank accession AC016484). This clone also contains the APBA2 gene which has been physically mapped to within the critical region for a 15q autistic disorder susceptibility locus, and outside the PWS/AS deletion region [4,5] (Fig. 1). An open reading frame of 472 amino acids was predicted from the genomic sequence of NDNL2 and is located within a single exon of the predicted gene. A series of expressed sequence tags (ESTs) were identified through a BLAST search of the EST database and were found to be part of the Unigene cluster Hs.94011. Assembly of the ESTs into a consensus sequence was performed and this sequence was compared to our sequence of IMAGE clones representing NDNL2 to arrive at a final sequence for the predicted protein (Fig. 2) (also see partial sequence in GenBank AF320911, MAGE-G).
###end p 10
###begin p 11
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Map of the human 15q11-q14 region.</bold>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APBA2</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 518 529 518 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APBA2/NDNL2</italic>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:9606">Human</span>
Map of the human 15q11-q14 region. Location of NDNL2 was derived from the Ensembl Human Genome server  and the physical location of APBA2, which is located on the same genomic clone as NDNL2. The large double-headed arrow indicates the common PWS/AS deletion, and BP2 and BP3 indicate the most common proximal and distal breakpoint regions. The breakpoint region for the largest inv dup (15) chromosome [27] and the autistic disorder susceptibility region [5] are also indicated. The physical distance between BP3 and APBA2/NDNL2 is as yet unknown due to the presence of repetitive elements in the intervening region.
###end p 11
###begin p 12
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence comparison of human <italic>NDNL2</italic> and mouse <italic>Ndnl2</italic> sequence.</bold>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
Sequence comparison of human NDNL2 and mouse Ndnl2 sequence. The human and mouse predicted amino acid sequences are aligned with conserved amino acids shaded. Partial sequence of two cDNA clones has been included for comparison of the predicted translation with the longer human open reading frame. The predicted position of a MAGE-like nonapeptide present in other MAGE proteins is underlined.
###end p 12
###begin p 13
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1081 1082 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1249 1254 1249 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1368 1369 1368 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1372 1377 1372 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 492 498 <span type="species:ncbi:10090">murine</span>
###xml 554 559 <span type="species:ncbi:9606">human</span>
###xml 636 641 <span type="species:ncbi:9606">human</span>
###xml 737 743 <span type="species:ncbi:10090">murine</span>
###xml 949 955 <span type="species:ncbi:10090">murine</span>
###xml 1000 1005 <span type="species:ncbi:9606">human</span>
The sequence for murine Ndnl2 was identified using sequence data obtained from homology searches of mouse ESTs (UniGene cluster Mm.19944). Comparison of the sequence from multiple cDNAs revealed that the predicted mouse protein has 279 amino acids and has 83% sequence identity with the human protein (Fig. 2). As with other NDN/MAGE family members, the maximum sequence conservation is in the C-terminus of the protein, suggesting a common function for this domain among family members. The murine protein is truncated at the N terminus compared to the human protein at the position equivalent to the methionine at position 168 in the human predicted protein, predicted based on the presence of a strong Kozak consensus surrounding the murine AUG, including a G at the minus three position. In at least two EST clones, including RIKEN clone AK010294 from a library enriched for full-length cDNAs, the predicted amino acids upstream of the putative murine start methionine are not conserved with the human sequence, in sharp contrast with those C-terminal to this methionine (Fig. 2). In addition, the lack of conservation does not appear to be due to the presence of an intron or a sequencing error. Closer inspection of the sequence revealed that NDNL2 contains only partial similarity to the antigenic nonapeptide characteristic of other MAGE family proteins (Fig. 2). Ndnl2 is identical in sequence to a predicted protein named "mage-g1" (GenBank accession AF319979).
###end p 13
###begin p 14
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 106 117 106 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. musculus</italic>
###xml 140 150 140 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. spretus</italic>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APBA2</italic>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Apba2</italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 106 117 <span type="species:ncbi:10090">M. musculus</span>
###xml 140 150 <span type="species:ncbi:10096|species:ncbi:180214">M. spretus</span>
###xml 518 523 <span type="species:ncbi:10090">Mouse</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 621 627 <span type="species:ncbi:10090">murine</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
We identified a DNA polymorphism within Ndnl2 by direct sequencing of a 469 bp PCR product amplified from M. musculus strain C57BL/6JEi and M. spretus SPRET/Ei DNA. The presence of a T to C transition at position 42 of AV005659 abolishes an Msp I site in C57BL/6JEi that is present in SPRET/Ei. By genotyping the Jackson laboratory BSS backcross derived from the cross (C57BL/6JEi x SPRET/Ei)F1 x SPRET/Ei), we demonstrated linkage of Ndnl2 to chromosome 7, at a position genetically inseparable from that of Ndn (see Mouse Genome Informatics,  for details). As predicted from the location of human APBA2 near NDNL2, the murine Apba2 gene is also located in the central region of Chr 7, but the use of different mapping panels for the two genes does not permit their relative order to be established [17]. Based on the high sequence similarity between human and mouse sequences and on the location in a region of conserved synteny we conclude that the NDNL2 andNdnl2 genes are orthologous in these two species.
###end p 14
###begin p 15
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndn</italic>
###xml 848 854 848 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Magel2</italic>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlxin</italic>
###xml 890 896 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGED1</italic>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 277 282 <span type="species:ncbi:9606">human</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
###xml 618 623 <span type="species:ncbi:10090">mouse</span>
###xml 870 876 <span type="species:ncbi:10090">murine</span>
The expression of NDNL2 and Ndnl2 was analyzed by northern blot studies (Fig. 3). The observed 1.9 kb RNA transcript roughly corresponds in size to the 1.5 kb cDNA present in IMAGE clone 1134795, which likely contains most of the transcript. The transcript was observed in all human tissues tested, and appeared to be most abundant in testis after adjustments were made for RNA loading. Expression in mouse is also widespread, with a moderately abundant 1.7 kb transcript observed in all tissues tested consistent with the 1.5 kb insert size for cDNA clone RIKEN ID 1010001J10. The origin of the smaller transcript in mouse testis is unknown but may represent an alternative polyadenylation site or alternative transcriptional start site. It is notable that expression of NDNL2/Ndnl2 is widespread although for other family members, including Ndn, Magel2 and Dlxin, the murine homologue of MAGED1, expression is more spatially and temporally limited [12,18,19].
###end p 15
###begin p 16
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression analysis necdin-like 2 in embryonic and adult human and mouse tissues.</bold>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 303 308 <span type="species:ncbi:10090">mouse</span>
Expression analysis necdin-like 2 in embryonic and adult human and mouse tissues. (A) Northern blots of adult (left and center) and fetal (right) human tissues. The 1.9 kb NDNL2 transcript is indicated by the arrow. Size markers are as indicated. (B) Northern blot of adult (left) and embryonic (right) mouse tissues shows expression of a 1.7 kb transcript (arrow).
###end p 16
###begin p 17
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 545 548 545 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1001 1008 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1196 1203 1196 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1441 1442 1441 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1642 1644 1642 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1707 1712 1707 1712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1832 1837 1832 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1873 1875 1873 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2060 2065 2060 2065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 2113 2118 2113 2118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 2136 2141 2136 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 2221 2223 2221 2223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 488 493 <span type="species:ncbi:10090">mouse</span>
###xml 538 544 <span type="species:ncbi:10090">murine</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
###xml 1802 1810 <span type="species:ncbi:9606">patients</span>
Previous studies have suggested that the imprinted domain on chromosome 15q is limited to a region of about 1.5 Mb surrounding the imprinting center [20,21]. However, given the observed parent-of-origin effects in chromosomal disorders of chromosome 15 [4], we performed experiments to analyze the imprinting of NDNL2 and Ndnl2. To test imprinting of Ndnl2, we examined newborn brain, liver and lung, and embryonic day 12.5 whole embryo RNA samples from the offspring of an interspecific mouse cross for allelic expression using the same murine MspI polymorphism as used for genetic mapping. Both parental alleles were detected equally, indicating that expression of Ndnl2 is not imprinted (Fig. 4A). We were unable to identify an intragenic polymorphism in NDNL2 that would allow direct evaluation of the levels of expression of each allele. Instead, we evaluated the effect of deletion of the chromosome 15q11-q13 imprinting center (IC) on the expression of NDNL2. Sporadic PWS and AS patients with de novo deletions not only have a loss of the genes located inside the deletion interval, they also have a loss of the imprinting control element located therein. In a previous study, a somatic, de novo deletion of the IC impaired imprinting of target genes [22]. These target genes are not necessarily limited to the region typically deleted in PWS and AS, which is defined by unstable genomic elements located at the deletion boundaries [1], but could include other genes within the range of the imprinting center. However, our previous study had predicted that it is unlikely that the range of the IC extended beyond the deletion itself [20]. To test this hypothesis and to examine the possibility that NDNL2 is acted on by the IC, we tested the effect of the loss of the IC in sporadic PWS and AS patients on the expression of NDNL2. Using a previously defined assay [20], RNA from lymphoblast and fibroblast cell lines that carry either a paternal 15q11-q13 deletion (PWS) or the equivalent maternal deletion (AS) were tested by RT-PCR for expression of NDNL2. On repeated trials, both cell lines expressed NDNL2, indicating that NDNL2 is not imprinted by the imprinting center located in the deletion region (Fig. 4B).
###end p 17
###begin p 18
###xml 23 34 23 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/Ndnl2</italic>
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Imprinting analysis of <italic>NDNL2/Ndnl2</italic></bold>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNRPN</italic>
Imprinting analysis of NDNL2/Ndnl2. (A) Restriction digestion of PCR of genomic DNA from C57BL/6, SPRET and an F1 offspring demonstrating the interspecific polymorphism, RT-PCR of tissues (nb = newborn) from the F1 offspring. Note that both alleles are active. (B) RT-PCR of fibroblast (FB) and lymphoblast (LCL) RNA from PWS, AS and control samples. NDNL2 is expressed in all cell lines whereas SNRPN is not expressed in PWS cell lines (i.e. is imprinted).
###end p 18
###begin p 19
###xml 10 21 10 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/Ndnl2</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 282 294 282 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGEL2/NDNL1</italic>
###xml 300 312 300 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2/MAGE-G</italic>
###xml 341 347 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGE-D</italic>
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGE-E</italic>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGE-F</italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 399 406 399 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGE-D,</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRAGE</italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dlxin</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 437 442 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
The names NDNL2/Ndnl2 have been approved by the human and mouse nomenclature committees, based on sequence similarity to NDN and chromosomal localization. In a recent review of the NDN/MAGE gene family, a multiple sequence alignment clustered the chromosome 15 family members (NDN, MAGEL2/NDNL1, and NDNL2/MAGE-G) together with the X-linked MAGE-D, MAGE-E and chromosome 3-linked MAGE-F genes [23]. MAGE-D, known more commonly as NRAGE (human) or dlxin (mouse) may be ancestral to other members of the NDN/MAGE gene family. We recommend that the human and mouse nomenclature committees evaluate the arguments for the names of genes in this gene family to establish a unified nomenclature that clarifies the relationships among the family members.
###end p 19
###begin p 20
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGED1</italic>
###xml 271 282 271 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRAGE/dlxin</italic>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 913 918 913 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 947 952 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1094 1099 1094 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 841 849 <span type="species:ncbi:9606">patients</span>
Necdin was originally identified as a gene induced on neuronal differentiation of embryonic carcinoma cells, but has more recently been implicated in PWS. Members of the MAGE gene family are recognized for their expression in tumor cells, and a new family member MAGED1 (NRAGE/dlxin) is postulated to have roles in chondrogenesis, neurotrophin signaling and apoptosis [19,24,25]. Although the widespread expression of NDNL2 does not immediately suggest a role in the neurodevelopmental disorders associated with abnormalities of chromosome 15, NDNL2 is located within the broad region associated with developmental disorders. In particular, the location of NDNL2 near D15S1019, proximal to D15S165 implies that copies of NDNL2 are present on most phenotypically relevant inv dup(15) chromosomes [26,27] and may contribute to the findings in patients carrying these supernumerary chromosomes through a doubling of NDNL2 expression levels. However, NDNL2 is outside the more narrowed interstitial duplication interval associated with some autistic phenotypes [28], although long range effects on NDNL2 expression may still occur.
###end p 20
###begin title 21
Conclusions
###end title 21
###begin p 22
Given the wide range of processes that members of this intriguing gene family participate in and the possibility of redundant function within the gene family, we suggest that the 15q NDN/MAGE family members be considered as candidates for involvement in the neurodevelopmental disorders associated with chromosome 15q.
###end p 22
###begin title 23
Materials and methods
###end title 23
###begin title 24
cDNA clones
###end title 24
###begin p 25
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
###xml 339 344 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
Human and mouse cDNAs were obtained from Research Genetics or the MRC Genome Resource Facility and were sequenced using the Thermo Sequenase fluorescent labeled primer cycle sequencing kit with 7-deaza dGTP (Amersham-Phamacia Biotech, Buckinghamshire, England) and LiCor technology (LiCor 4200 Automatic Sequencer, Lincoln, Nebraska). The human cDNA was represented by IMAGE clone 1147395; mouse cDNAs were IMAGE clones 483464, 2101532 and RIKEN #1010001J10.
###end p 25
###begin title 26
Northern blot expression studies
###end title 26
###begin p 27
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDNL2</italic>
###xml 464 466 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1174 1179 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 1405 1410 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
###xml 597 602 <span type="species:ncbi:9606">human</span>
###xml 696 699 <span type="species:ncbi:9685">Cat</span>
###xml 1071 1076 <span type="species:ncbi:10090">mouse</span>
###xml 1266 1271 <span type="species:ncbi:10090">Mouse</span>
###xml 1300 1303 <span type="species:ncbi:9685">Cat</span>
A PCR product derived from the 3' end of human NDNL2 was generated with oligonucleotide primers NDNL2-3F (5'-GTCTACCCCACCAAGAAGCA) and NDNL2-4R (5'-CCTTCCCCCAATCCTCTAAA), in a 20 mul PCR reaction containing 20 pmol of each oligonucleotide. The PCR was performed as follows: 94degreesC for 5 min. followed by 30 cycles of 94degreesC for 30 s, 52degreesC for 30 s, 72degreesC for 30 s, and final extension at 72degreesC for 10 min., The PCR product was random prime 32P-dCTP labeled with the Random Primers DNA Labeling System (Life Technologies, Rockville, MD). The labeled probe was hybridized to human adult and fetal Multiple Tissue Northern (MTN) Blots (Clontech Laboratories, Palo Alto, CA., Cat. #7760-1, 7759-1 and 7756-1) in ExpressHyb solution according to manufacturer's directions. The final wash was at 50degreesC in 0.1XSSC, 0.1%SDS twice for 20 min each time. Exposure to Hyperfilm (Amersham-Pharmacia Biotech) was for four days at -80degreesC. Oligonucleotide primers Ndnl2-1F (5'-CTTGGAGTACCGGAGGATACC) and Ndnl2-2R (5'-CAACACATCCTAACGCTCCA) were used for mouse northern blots. These primers amplified a 343 bp DNA fragment corresponding to the 3' end of the Ndnl2 gene. The PCR was performed as above but with an annealing temperature of 58degreesC. Mouse adult and embryo MTN blots (Cat. #7762-1 and 7763-1, Clontech Laboratories) were similarly hybridized with the radioactively labeled Ndnl21F/2R PCR product. To control for the amount of loaded RNA the same blot was subsequently hybridized with a beta-actin or ubiquitin probe demonstrating approximately equal loading in all lanes.
###end p 27
###begin title 28
Genetic mapping and imprinting studies
###end title 28
###begin p 29
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndnl2</italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msp</italic>
###xml 455 466 455 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. spretus.</italic>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 455 465 <span type="species:ncbi:10096|species:ncbi:180214">M. spretus</span>
###xml 560 565 <span type="species:ncbi:9606">human</span>
###xml 664 669 <span type="species:ncbi:9606">Human</span>
A 469 bp product corresponding to the 3' end of Ndnl2 was generated from mouse genomic DNA (C57BL/J or SPRET/Ei) using oligonucleotide primers Ndnl2-7F (5'-TGGAAACCAGCAAGATGAAA) and Ndnl2-8R (5'-AGCTACCCTGTTTCTTTATCGTC). DNA samples were sequenced on both strands using the LiCor automated sequencer. DNA amplification products were digested with MspI to produce a 469 bp undigested product in C57BL/6J and 180 bp and 289 bp digested products in DNA from M. spretus. Genetic mapping was performed on the Jackson Laboratories BSS backcross. Cell lines used for human imprinting analysis were PWS lymphoblast GM09024B and AS lymphoblast GM11515 (both from the NIGMS Human Genetic Mutant Cell Repository), PWS fibroblast 1889 from the University of Miami Brain and Tissue Bank for Developmental Disorders and AS fibroblast KAT graciously provided by Dr. A. Beaudet (Baylor College of Medicine).
###end p 29
###begin title 30
List of abbreviations
###end title 30
###begin p 31
AS (Angelman syndrome), ESTs, (expressed sequence tags), IC (imprinting center), PWS (Prader-Willi syndrome).
###end p 31
###begin title 32
Acknowledgements
###end title 32
###begin p 33
###xml 59 65 <span type="species:ncbi:10090">murine</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
We thank Mary Barter from the Jackson Laboratories for the murine haplotype analysis, the MRC Genome Resource Facility and the RIKEN Genome Science Center for DNA clones, and Dr. A. Beaudet for the AS fibroblast cell line. Samples used in this study were provided by the University of Miami Brain and Tissue Bank for Developmental Disorders through NICHD contract # NO1-HD-8-3284. This work was supported in part by a Research Grant No. 6-FY00-196 from the March of Dimes Birth Defects Foundation, Summer Studentships to T.K.C. from the Alberta Heritage Foundation for Medical Research (AHFMR) and the Canadian Genetic Disease Network. R.W. is a Scholar of the AHFMR and the Canadian Institutes of Health Research. Research involving human subjects and animals has been performed in accordance with the Institutional policies of the University of Alberta.
###end p 33
###begin article-title 34
Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints.
###end article-title 34
###begin article-title 35
Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13).
###end article-title 35
###begin article-title 36
The impact of genomic imprinting for neurobehavioral and developmental disorders.
###end article-title 36
###begin article-title 37
Autistic disorder and chromosome 15q11-q13: construction and analysis of a BAC/PAC contig.
###end article-title 37
###begin article-title 38
Genetic studies in autistic disorder and chromosome 15.
###end article-title 38
###begin article-title 39
De novo truncation mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.
###end article-title 39
###begin article-title 40
UBE3A/E6-AP mutations cause Angelman syndrome.
###end article-title 40
###begin article-title 41
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse.
###end article-title 41
###begin article-title 42
From the cover: identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization.
###end article-title 42
###begin article-title 43
Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which Is highly expressed in brain.
###end article-title 43
###begin article-title 44
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGEL2</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region.
###end article-title 44
###begin article-title 45
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAGEL2</italic>
###xml 95 101 <span type="species:ncbi:10090">murine</span>
Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype.
###end article-title 45
###begin article-title 46
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NDN</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region.
###end article-title 46
###begin article-title 47
Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome.
###end article-title 47
###begin article-title 48
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Disruption of the mouse necdin gene results in early postnatal lethality: a model for neonatal distress in Prader-Willi syndrome.
###end article-title 48
###begin article-title 49
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Disruption of the mouse necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome.
###end article-title 49
###begin article-title 50
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 25 31 <span type="species:ncbi:10090">murine</span>
###xml 70 76 <span type="species:ncbi:10090">murine</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Mapping of the human and murine X11-like genes (APBA2 and apba2), the murine Fe65 gene (Apbb1), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor protein.
###end article-title 50
###begin article-title 51
Cell cycle regulators in neural stem cells and postmitotic neurons.
###end article-title 51
###begin article-title 52
Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function.
###end article-title 52
###begin article-title 53
Identification of novel imprinted transcripts in the Prader-Willi/Angelman syndrome deletion region: further evidence for regional imprinting control.
###end article-title 53
###begin article-title 54
Large-scale evaluation of imprinting status in the Prader-Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes.
###end article-title 54
###begin article-title 55
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">De novo</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNRPN</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
De novo deletions of SNRPN exon 1 in early human and mouse embryos result in a paternal to maternal imprint switch.
###end article-title 55
###begin article-title 56
###xml 67 72 <span type="species:ncbi:9606">human</span>
An overview of the MAGE gene family with the identification of all human members of the family.
###end article-title 56
###begin article-title 57
NRAGE is an inducible IAP-interacting protein that augments cell death.
###end article-title 57
###begin article-title 58
NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.
###end article-title 58
###begin article-title 59
Molecular cytogenetic evidence for a common breakpoint in the largest inverted duplications of chromosome 15.
###end article-title 59
###begin article-title 60
Isolation and molecular analysis of inv dup(15) and construction of a physical map of a common breakpoint in order to elucidate their mechanism of formation.
###end article-title 60
###begin article-title 61
Interstitial duplications of chromosome region 15q11q13: clinical and molecular characterization.
###end article-title 61

